This report describes a review of New Jersey exposure calls involving tianeptine, an atypical tricyclic antidepressant that has not been approved by the Food and Drug Administration, but which is available for purchase in elixir formulations online and in gas stations.
This article reports on a retrospective review of exposure calls involving tianeptine exposure which were identified in the New Jersey Poison Information and Education System’s Toxicall database, from June 17 to November 6, 2023. It describes 20 cases of tianeptine ingestions (often sold as “gas station heroin”) during that time period, with severe associated clinical effects with synthetic cannabinoid receptor agonists (SCRAs) identified in samples of the ingested products. The article emphasizes that postmortem forensic toxicology testing suggests a high potential for substantial clinical effects of tianeptine products, and encourages members of the public and health care professionals to be aware that it is an unregulated drug which may cause adverse effects as well as dependence, and is sold under several product names, including Neptune’s Fix, Pegasus, and Zaza.
Downloads
Similar Publications
- Family Structure and Secondary Exposure to Violence in the Context of Varying Neighborhood Risks and Resources
- The New Solitary Confinement? A Conceptual Framework for Guiding and Assessing Research and Policy on "Restrictive Housing"
- The Lichtenberg Financial Decision Screening Scale (LFDSS): A new tool for assessing financial decision making and preventing financial exploitation